FDA Approved: GABAPENTIN — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for gabapentin from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (ANDA211314).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Postherpetic Neuralgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)